A Potential Biomarker for Predicting Schizophrenia: Metallothionein-1

A Potential Biomarker for Predicting Schizophrenia: Metallothionein-1

It has been thought that oxidative damage may occur in the pathophysiology of schizophrenia; metallothioneins (MT) have strong antioxidant functions. In this study, we aimed to measure MT-1 levels in schizophrenia patients. A total of 52 patients diagnosed with schizophrenia and 38 healthy controls...

Full description

Bibliographic Details
Main Authors:	Seda Yılmaz, Nülüfer Kılıç, Şüheda Kaya, Gülay Taşcı
Format:	Article
Language:	English
Published:	MDPI AG 2023-02-01
Series:	Biomedicines
Subjects:	antioxidant Metallothionein-1 schizophrenia PANSS Cu/Zn
Online Access:	https://www.mdpi.com/2227-9059/11/2/590

Similar Items

Metallothionein /
by: 408271 Hamer, Dean H.

Metallothionein /
by: 314566 Dunn, Michael A., et al.

Relationship of Neuropeptide S with Clinical and Metabolic Parameters of Patients during Rehabilitation Therapy for Schizophrenia
by: Agnieszka Markiewicz-Gospodarek, et al.
Published: (2022-06-01)

Suicidal tendencies in Schizophrenia patients
by: A. Pascariu, et al.
Published: (2022-06-01)

Accelerated pace of frailty in patients with schizophrenia
by: Shun Yao, et al.
Published: (2025-01-01)

Anti-metallothionein IgG and levels of metallothionein in autistic families
by: A Russo
Published: (2008-02-01)

Metallothioneins : proteins in search of function /
by: 336230 Karin, Michael

Metallothioneins : proteins in search of function /
by: 336262 Moody, John R., et al.

Biochemistry of metallothionein /
by: 408047 Kagi, Jeremias H. R., et al.

Abnormalities of the Amygdala in schizophrenia: a real world study
by: Guangen Zheng, et al.
Published: (2023-08-01)

Overlapping of clinical symptoms between schizophrenia and bipolar disorder
by: A. Tahirovic, et al.
Published: (2022-06-01)

Metallothionein III : biological roles and medical implications /
by: Suzuki, Kazuo T., et al.
Published: (1993)

Relation of IGF-I and IGFBP5 gene expression levels in Schizophrenia patients
by: Sevgi Karabulut Uzunçakmak, et al.
Published: (2020-05-01)

Relationship between plasma TNF-α levels and agitation symptoms in first episode patients with schizophrenia
by: Xiaoying Wang, et al.
Published: (2024-07-01)

Gram scale purifiction and preparation of rabbit liver zinc metallothionein /
by: 212743 Comeau, R. D.

Relation of Vitamin D levels with positive and negative symptoms of schizophrenia – A hospital based cross-sectional comparative study
by: Soumitra Ghosh, et al.
Published: (2023-09-01)

Metllotioneins: synthesis, structure and properties of metallothioneins, polytochelations and metal-thiolate complexes/
by: Stillman, Martin J., et al.
Published: (1992)

Shorter Chain Triglycerides Are Negatively Associated with Symptom Improvement in Schizophrenia
by: Anna Tkachev, et al.
Published: (2021-05-01)

Peripheral blood complement factors C2 and C3 as biomarkers of clinical efficacy in patients with first-episode schizophrenia after aripiprazole treatment
by: Yin Cao, et al.
Published: (2024-12-01)

Variations in inflammatory regulators in male patients with chronic schizophrenia associated with psychopathology and cognitive deficits
by: Tianming Guo, et al.
Published: (2024-11-01)

Pharmacist-led Si-care (schizophrenia care) model to improve medication adherence and symptom management in schizophrenia
by: Noor Cahaya, et al.
Published: (2024-12-01)

Neuropeptide Y in first-episode schizophrenia: is there any sex differences in the pathogeneses of schizophrenia?
by: Jia-Qi Song, et al.
Published: (2024-12-01)

Standardized training in the rating of the six-item positive and negative syndrome scale (PANSS-6)
by: P. Kølbæk, et al.
Published: (2021-04-01)

Population Pharmacodynamic Models of Risperidone on PANSS Total Scores and Prolactin Levels in Schizophrenia
by: Zhiwei Huang, et al.
Published: (2024-01-01)

Association between treatment resistance and cognitive function in schizophrenia
by: Jiaqian Sun, et al.
Published: (2024-10-01)

Multifunctional Metallothioneins as a Target for Neuroprotection in Parkinson’s Disease
by: Ikuko Miyazaki, et al.
Published: (2023-04-01)

Research progress of metallothionein in metabolic diseases
by: YANG Yan
Published: (2022-03-01)

Assessment of Knowledge on Metal Trace Element Concentrations and Metallothionein Biomarkers in Cetaceans
by: Vincent Leignel, et al.
Published: (2023-05-01)

Neurofeedback technique for treating male schizophrenia patients with impulsive behavior: a randomized controlled study
by: Zhenkuo Li, et al.
Published: (2024-10-01)

The role of metallothionein in breast cancer
by: Sara Bilić-Knežević, et al.
Published: (2022-01-01)

Antioxidant Defenses in the Human Eye: A Focus on Metallothioneins
by: Ana Álvarez-Barrios, et al.
Published: (2021-01-01)

Association between cognitive function, antioxidants, and clinical variables in Chinese patients with schizophrenia
by: Dan Li, et al.
Published: (2024-12-01)

Positive and negative syndromes in schizophrenia: analysis of determinants and severity of symptoms in Moroccan patients
by: Khadija Fritah, et al.
Published: (2024-11-01)

Examination of the Metallothionein Gene Family in Greater Duckweed <i>Spirodela polyrhiza</i>
by: Orathai Pakdee, et al.
Published: (2022-12-01)

Diagnostic value and role of serum miR-15a-5p in patients with schizophrenia
by: Zhen Xu, et al.
Published: (2024-01-01)

Exploring the relationship of cognitive function with and without COVID-19 recovered schizophrenic patients
by: Anam Mehmood, et al.
Published: (2024-01-01)

Efficacy of modified electroconvulsive therapy as augmentation agent in treatment-resistant schizophrenia
by: Chitrakshee Singh, et al.
Published: (2024-09-01)

Metallothionein: A Comprehensive Review of Its Classification, Structure, Biological Functions, and Applications
by: Ruoqiu Yang, et al.
Published: (2024-07-01)

Surface expression of metallothionein enhances bioremediation in Escherichia coli
by: Nan He, et al.
Published: (2024-01-01)

Metallothionein and Cadmium Toxicology—Historical Review and Commentary
by: Monica Nordberg, et al.
Published: (2022-02-01)